Company profile for Finch Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative microbial therapies. Finch is a different breed of biotech. Built by combining two leading microbiome companies – Finch Therapeutics and Crestovo – our company is led by data-driven, mission-oriented innovators and experts in the biotech field who are driven to advance the foundational clinical work of mi...
Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative microbial therapies. Finch is a different breed of biotech. Built by combining two leading microbiome companies – Finch Therapeutics and Crestovo – our company is led by data-driven, mission-oriented innovators and experts in the biotech field who are driven to advance the foundational clinical work of microbiome pioneers to the benefit of patients. Our technical approach marries traditional drug development techniques a unique human-first discovery platform and pursues both Full-Spectrum Microbiota.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 Inner Belt Road, Suite 400 Somerville, MA, 02143
Telephone
Telephone
617-229-6499
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/10/21/2966095/0/en/Finch-Announces-Delisting-from-Nasdaq-and-SEC-Deregistration.html

GLOBENEWSWIRE
21 Oct 2024

https://www.globenewswire.com/news-release/2023/06/09/2685438/0/en/Finch-Announces-Reverse-Stock-Split-of-Common-Stock.html

GLOBENEWSWIRE
09 Jun 2023

https://www.globenewswire.com/news-release/2023/05/10/2665380/0/en/Finch-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Provides-Business-Updates.html

GLOBENEWSWIRE
10 May 2023
Finch continues to pinch pennies to stretch cash into 2025
Finch continues to pinch pennies to stretch cash into 2025

24 Mar 2023

// Gabrielle Masson FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/finch-pinches-pennies-stretching-cash-2025-after-layoffs-and-trial-discontinuation

Gabrielle Masson FIERCE BIOTECH
24 Mar 2023

https://www.globenewswire.com/news-release/2023/03/23/2633655/0/en/Finch-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Business-Updates.html

GLOBENEWSWIRE
23 Mar 2023

https://www.fiercebiotech.com/biotech/frosty-funding-forecast-forces-finch-stop-phase-3-trial-lay-95-staff-and-seek-buyers-assets

FIERCE BIOTECH
25 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty